Zhitong Financial App News, Shiyao Group (01093.HK) announced that the pluglitine tablets (this product) developed by the Group recently obtained top-line analysis data in a phase III clinical trial of pluglitine, dapagliflozin, and metformin in combination treatment of patients with type 2 diabetes (T2DM).

Zhitongcaijing · 1d ago
Zhitong Financial App News, Shiyao Group (01093.HK) announced that the pluglitine tablets (this product) developed by the Group recently obtained top-line analysis data in a phase III clinical trial of pluglitine, dapagliflozin, and metformin in combination treatment of patients with type 2 diabetes (T2DM).